Navigation Links
Human, animal vaccine development goal of hepatitis E virus research
Date:3/7/2008

Blacksburg, Va.--Dr. X.J. Meng, of Blacksburg, Va., a professor of virology in the Virginia-Maryland Regional College of Veterinary Medicines Department of Biomedical Sciences and Pathobiology at Virginia Tech, has been awarded two research grants totaling almost $3 million from the National Institutes of Health (NIH) to study the hepatitis E virus (HEV). The ultimate goal of the work is to develop a vaccine to protect people and animals from Hepatitis E.

HEV is an important human pathogen, according to Meng. The disease caused by HEV, Hepatitis E, is a major public health problem in developing countries in Asia and Africa, and in Mexico. Hepatitis E is also endemic in the United States and many other industrialized countries, according to Meng. Although the overall mortality associated with HEV infection is generally low (less than 1 percent), it can be as high as 28 percent in infected pregnant women. Currently, there is no vaccine to prevent Hepatitis E.

The major obstacle for Hepatitis E research and vaccine development has been the lack of a practical animal model system for HEV research and the inability to propagate HEV in cell culture, explains Meng. With funding from NIH, Mengs group recently discovered two HEV-related animal viruses in the United States: swine hepatitis E virus (swine HEV) from pigs, and avian hepatitis E virus (avian HEV) from chickens. It has since been demonstrated that swine HEV can cross species barriers and infect humans, and that human HEV can infect pigs. Hepatitis E is now regarded as a zoonotic disease.

With the discoveries of the two new animal viruses, Mengs group quickly developed a pig model and a chicken model to study the hepatitis E virus. Prior to Mengs discoveries of the two animal hepatitis E viruses, scientists were forced to use non-human primates in order to study the disease. Conducting HEV research with primates at one of the NIH regional primate centers is expensive and contains some ethical concerns, according to Meng, so developing the new animal models will be a major step forward in the research.

The first NIH grant, entitled Mechanism of hepatitis E virus replication and pathogenesis, conveys total funding of $1,561,797 and the co-investigators are Dr. Patrick G. Halbur, and Dr. Yao-Wei Huang. The second grant, entitled A chicken model to study hepatitis E virus pathogenesis includes funding of $1,266,300 and the co-investigators are Dr. F. William Pierson, Dr. Tanya LeRoith, and Dr. Yao-Wei Huang. Both grants begin on March 1, 2008 and will support four years of work.

The grants will enable researchers to learn more about the molecular mechanisms of HEV replication and pathogenesis by using pigs and chickens as animal model systems. Specifically, the researchers will study how HEV causes hepatitis, the gene(s) that are responsible for virulence, the mechanism(s) for cross-species infection by HEV, and how to attenuate the virus for vaccine development purpose. Ultimately, the researchers hope to develop a vaccine against this important human pathogen.

Mengs laboratory in the colleges Center for Molecular Medicine and Infectious Disease (CMMID) is considered one of the worlds leading Hepatitis E virus research centers. Previously, he had received nearly $2 million dollars from the NIH to study the same virus. Meng currently chairs the Hepatitis E Virus study group on the International Committee on Taxonomy of Viruses (ICTV).

Funded by the United States Department of Agriculture and several private corporations, Mengs lab also studies several economically important animal viruses including porcine circovirues, and porcine reproductive and respiratory syndrome virus. Recently, Mengs lab successfully developed the first USDA fully-licensed vaccine, Suvaxyn PCV2 One Dose, against porcine circovirus associated diseases, an economically important swine disease worldwide. Virginia Tech has licensed the vaccine to Wyeth Inc. and Fort Dodge Animal Health Inc., and the vaccine is currently on the U.S. and Canadian markets, and has now begun to enter the global markets. The vaccine is saving millions of dollars each year for the swine industry.


'/>"/>

Contact: Jeff Douglas
jdouglas@vt.edu
540-231-7911
Virginia Tech
Source:Eurekalert

Related medicine news :

1. Pain Management For Your Pets, Key Information Every Pet Owner Should Know - Live Webcast to Pet Owners, March 13, 8:00 p.m. to 9:00 p.m. (EDT) Via Morris Animal Foundation
2. Pain Management For Pets, Key Strategies For Veterinarians - Live Webcast to Veterinarians, March 13, 7:00 p.m. to 8:00 p.m. (EDT) Via Morris Animal Foundation
3. Researchers create first chikungunya animal model
4. Animal Planet Pet Video to Provide 2 Million Free Training DVDs to New Pet Parents of Adopted Shelter Dogs and Cats
5. U.S. Seeks to Limit Animal Testing of Toxic Chemicals
6. Chicago Tribune Does Story on Canine Cancer, Morris Animal Foundation (MAF) Effort to Find a Cure - MAF Can Provide Information - Local Angles for a Feature Story
7. Photo: Animal Rescue League of Boston Receives $3 Million Grant to Establish a Center for Shelter Dogs
8. The Blue Buffalo Foundation for Cancer Research Sponsors Six Morris Animal Foundation Cancer Studies
9. Anpath Group, Inc. Announces Advancements with Animal Care Line
10. Wild Animal Crunch(TM) Helps Moms Tame Families Hunger
11. Plan expedites alternatives to animal testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... ... AlignLife clinics nationwide are giving back to their communities by collecting toys ... gifts wrapped tightly under a Christmas Tree. AlignLife hopes to spread the joy ... In exchange for generous donations, customers will receive a gift in return. Anyone ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... ... 07, 2016 , ... "ProBrand Flip allows FCPX editors to create unique logo ... CEO of Pixel Film Studios. , ProBrand Flip includes 30 flip book reveal animations. ... select from a variety of flip book animations. In Addition, users can modify each ...
(Date:12/7/2016)... ... ... “Tomorrow Trump Goes To Washington”: a brief but engaging illustration depicting the first ... Trump Goes To Washington” is the creation of published author, Nancy Engestrom, a hardworking ... attributes her patriotic nature to her WWII veteran father. She says, “I love ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... was honored to present at the International Probiotic Association’s Washington DC workshop on ... government regulators to engage in dialog regarding probiotic dietary supplement regulations. , ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... 2016 The pen needles market is projected ... 1.65 billion in 2016, growing at a CAGR of ... Over the years, the pen needles market has ... the growing demand for safety injections in the healthcare ... safety pen needles with an aim to reduce pain, ...
(Date:12/6/2016)...  BTL Aesthetics today announced the release of ... ME device was effectively redesigned for more efficient, ... tissue. The result: Significantly better outcomes in abdominal ... ME versus BTL Vanquish. "We are ... patients with the most highly-advanced devices on the ...
(Date:12/6/2016)... 6, 2016  Viking Therapeutics, Inc. ("Viking") (NASDAQ: ... focused on the development of novel therapies for ... U.S. Food and Drug Administration (FDA) has granted ... of X-linked adrenoleukodystrophy (X-ALD).  VK0214 is a novel, ... selectively regulates the expression of genes believed to ...
Breaking Medicine Technology: